Prevalence and nature of adverse medical device events in hospitalized children

Patrick W Brady1, Kartik Varadarajan, Laura E Peterson

  • 1Pediatric Center for Education and Research on Therapeutics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. patrick.brady@cchmc.org

Insights

Adverse medical device events (AMDEs) are common in children's hospitals, affecting 3.3% of admissions. Vascular access and nervous system devices were most frequent, particularly in young children with complex chronic conditions.

Area of Science:

  • Pediatric healthcare research
  • Medical device safety
  • Health informatics

Background:

  • Tertiary care children's hospitals manage complex pediatric populations.
  • Medical devices are integral to modern pediatric care.
  • Understanding adverse medical device events (AMDEs) is crucial for patient safety.

Observation:

  • A retrospective cohort study analyzed over 4 million inpatient admissions across 44 children's hospitals.
  • Data spanned from January 1, 2004, to December 31, 2011, using the Pediatric Health Information System (PHIS).
  • AMDEs were identified through specific diagnostic codes related to medical devices.

Findings:

  • 3.3% of pediatric inpatient admissions (136,465 out of 4,115,755) experienced at least one AMDE.
  • Vascular access and nervous system devices accounted for 44.4% of all pediatric AMDE admissions.
  • The majority of AMDE admissions (75.5%) involved children with complex chronic conditions, with the highest incidence in those aged 2 years or younger.

Implications:

  • AMDEs represent a significant burden in pediatric tertiary care settings.
  • Further research is needed to identify specific predictors and risk factors for AMDEs in children.
  • Improved understanding of AMDEs can inform strategies to enhance medical device safety and patient outcomes in pediatric populations.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
15
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
335
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
284
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.3K
Types of Reports II: Incident or Occurrence Report01:21

Types of Reports II: Incident or Occurrence Report

An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
1.3K